null

SMILES: NC(=N)c1ccc(CC(=O)NCC(=O)N2CCN(CC(O)=O)C(=O)[C@@H]2CC(O)=O)cc1

InChI Key: InChIKey=KMXIJCGQJFYWTC-ZDUSSCGKSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50062804   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Integrin alpha-IIb/beta-3 (Homo sapiens (Human))	BDBM50062804 (((S)-1-{2-[2-(4-Carbamimidoyl-phenyl)-acetylamino]...) Show SMILES NC(=N)c1ccc(CC(=O)NCC(=O)N2CCN(CC(O)=O)C(=O)[C@@H]2CC(O)=O)cc1 Show InChI InChI=1S/C19H23N5O7/c20-18(21)12-3-1-11(2-4-12)7-14(25)22-9-15(26)24-6-5-23(10-17(29)30)19(31)13(24)8-16(27)28/h1-4,13H,5-10H2,(H3,20,21)(H,22,25)(H,27,28)(H,29,30)/t13-/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	8.10	n/a	n/a	n/a	n/a	n/a	n/a
Takeda Chemical Industries, Ltd. Curated by ChEMBL					Assay Description Ability to inhibit binding of biotin-labeled human fibrinogen to immobilized fibrinogen receptor purified from human erythroleukemia(HEL) cells.				J Med Chem 41: 489-502 (1998) Article DOI: 10.1021/jm970235u BindingDB Entry DOI: 10.7270/Q2571B4W
					More data for this Ligand-Target Pair
Integrin alpha-IIb/beta-3 (Homo sapiens (Human))	BDBM50062804 (((S)-1-{2-[2-(4-Carbamimidoyl-phenyl)-acetylamino]...) Show SMILES NC(=N)c1ccc(CC(=O)NCC(=O)N2CCN(CC(O)=O)C(=O)[C@@H]2CC(O)=O)cc1 Show InChI InChI=1S/C19H23N5O7/c20-18(21)12-3-1-11(2-4-12)7-14(25)22-9-15(26)24-6-5-23(10-17(29)30)19(31)13(24)8-16(27)28/h1-4,13H,5-10H2,(H3,20,21)(H,22,25)(H,27,28)(H,29,30)/t13-/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	1.60E+3	n/a	n/a	n/a	n/a	n/a	n/a
Takeda Chemical Industries, Ltd. Curated by ChEMBL					Assay Description Concentration required to inhibit adenosine diphosphate (ADP) induced aggregation of guinea pig platelets by 50% in vitro				J Med Chem 41: 489-502 (1998) Article DOI: 10.1021/jm970235u BindingDB Entry DOI: 10.7270/Q2571B4W
					More data for this Ligand-Target Pair
Integrin alpha-IIb/beta-3 (Homo sapiens (Human))	BDBM50062804 (((S)-1-{2-[2-(4-Carbamimidoyl-phenyl)-acetylamino]...) Show SMILES NC(=N)c1ccc(CC(=O)NCC(=O)N2CCN(CC(O)=O)C(=O)[C@@H]2CC(O)=O)cc1 Show InChI InChI=1S/C19H23N5O7/c20-18(21)12-3-1-11(2-4-12)7-14(25)22-9-15(26)24-6-5-23(10-17(29)30)19(31)13(24)8-16(27)28/h1-4,13H,5-10H2,(H3,20,21)(H,22,25)(H,27,28)(H,29,30)/t13-/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	1.20E+3	n/a	n/a	n/a	n/a	n/a	n/a
Takeda Chemical Industries, Ltd. Curated by ChEMBL					Assay Description Concentration required to inhibit adenosine diphosphate (ADP) induced aggregation of human platelets by 50% in vitro.				J Med Chem 41: 489-502 (1998) Article DOI: 10.1021/jm970235u BindingDB Entry DOI: 10.7270/Q2571B4W
					More data for this Ligand-Target Pair